Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Global | 2014 | Market Analysis

The mature global CRM device market will expand until 2019, primarily driven by favorable demographics and the launch of premium-priced novel devices such as MRI-compatible devices, leadless pacemakers, and S-ICDs. By 2022, the market will undergo a slight decline as price erosion takes place across all segments.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the global cardiac rhythm management device market across a 10-year period.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe (Supplemental)
The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and…
Report
Cardiac Rhythm Management Devices | Market Insights | Europe | 2024
The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs…